BSGM Nasdaq Profile
_______ OUR NEW PROFILE IS: (NASDAQ: BSGM) BIOSIG’S NEW PURE EP™ SUBSCRIPTION MODEL ADOPTED BY MAYO CLINIC-PHOENIX FOR WORLD-CLASS CARDIAC CARE OVER 3,000 PROCEDURES HAVE BEEN PERFORMED USING THE PURE EP™ SYSTEM WITH MORE THAN 80 PHYSICIANS AT 21 HOSPITALS ACROSS THE UNITED STATES SUBSTANTIAL AND GROWING IP PATENT PORTFOLIO IN 2022 THE CEO PURCHASED […]
(NASDAQ: WLDS) Profile
OUR NEW PROFILE IS: (NASDAQ: WLDS) THE ENTIRE FLOAT IS UNDER 8 MILL RIGHT NOW!!! Wearable Devices Unveils New Gesture & Voice-Controlled Interface for its Mudra Band for Apple Watch Wearable Devices Expands Mudra Licensing Program to Include Defense and Military Applications Wearable Devices Entered an MOU with a Leading XR Smart Glasses OEM for its […]
(NASDAQ: SVRE) Profile
OUR NEW PROFILE IS: (NASDAQ: SVRE) ~4,300 SYSTEMS HAVE BEEN ORDERED BY CUSTOMERS ~4X (286%) YEAR-OVER-YEAR GROWTH IN REVENUE T0 $399K IN THE FIRST HALF OF 2023 ~SAVERONE SYSTEM INSTALLED ON 30 DELIVERY TRUCKS OF TEMPO BEVERAGES- ISRAEL’S LEADING BEVERAGE COMPANY READ THE INVESTOR PRESENTATION HERE _________________ Hello Everyone, We have another Nasdaq profile sitting […]
(Nasdaq: NMTC) Profile
OUR NEW PROFILE IS: (NASDAQ: NMTC) STRATEGIC PARTNERSHIP WITH ZIMMER BIOMET (NYSE:ZBH, ~$27B MKT CAP) TO EXCLUSIVELY COMMERCIALIZE AND DISTRIBUTE EVO® DIAGNOSTIC ELECTRODES; ACCELERATED PAYMENT OF $3.5 MILLION RECEIVED IN AUGUST 2022 NMTC HAS NO DEBT OUTSTANDING AS OF JUNE 30, 2023 NEUROONE® SUCCESSFULLY COMPLETES INITIAL ANIMAL IMPLANT OF NOVEL THIN FILM PADDLE LEAD FOR […]
(NASDAQ: THAR) Profile
OUR NEW PROFILE IS: (NASDAQ: THAR) _________________ WHEN WE LOOKED AT THIS ONE BACK IN FEB IT RAN OVER 100% IN JUST 6 SESSIONS THAR HAS A FLOAT OF JUST UNDER 12 MILLION RIGHT NOW READ THE INVESTOR PRESENTATION HERE ___________________ Hello Everyone, We have another profile for you to watch pull […]
(Nasdaq: NCPL) Profile
REVENUE GROWTH OF 55% YEAR-OVER-YEAR TO $8.5 MILLION AS COMPARED TO $5.5 MILLION IN FISCAL 2022 FIRST QUARTER OF FISCAL YEAR 2023 SHOWED REVENUE GROWTH OF 13% YEAR-OVER-YEAR TO $1.5 MILLION, COMPARED TO REVENUE OF $1.3 MILLION IN THE PREVIOUS YEAR THE COMPANY BOASTS MORE THAN 100,000 USERS ALREADY WITH OVER $5O MILLION RAISED SO FAR THIS […]
(Nasdaq: TRNR) Profile
OUR NEW PROFILE IS: (NASDAQ: TRNR) ___________________________________ IN MAY, FORME ANNOUNCED A PARTNERSHIP WITH AETHOS, A HOTEL BRAND WITH LOCATIONS IN PORTUGAL, SPAIN AND ITALY THAT WILL PUT FORME’S CONNECTED FITNESS MIRRORS IN ALL OF ITS HOTELS AND MEMBER CLUBS. ANNUALIZED RECURRING REVENUE PER HOUSEHOLD IN Q1 2023 MORE THAN TRIPLES YOY TO $1,650 LAST MONTH, THE COMPANY ANNOUNCED A DISTRIBUTION PARTNERSHIP WITH THE […]
(Nasdaq: TLSA) Profile
OUR NEW PROFILE IS: (NASDAQ: TLSA) READ THE INVESTOR PRESENTATION HERE HELLO EVERYONE, We have a new profile for Monday’s session. This is another company that we have never looked at before on this newsletter before. Pull up TLSA right away. Historically, monoclonal antibodies, such as blockbuster drug, Humira®, have performed as the best selling drugs in […]
Nasdaq: ATAI Profile
OUR NEW PROFILE IS: (NASDAQ: ATAI) __________ CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $227.5 MILLION AS OF JUNE 30, 2023 ATAI OFFERS A DIVERSE PIPELINE OF DRUGS AND A FOCUS ON COMPOUNDS WITH PRIOR EVIDENCE IN HUMANS, UPCOMING INFLECTION POINTS (MULTIPLE PHASE 1 AND PHASE 2 PROOF-OF-CONCEPT TRIAL READOUTS ARE EXPECTED IN THE NEXT […]
(Nasdaq: NLSP) Profile
OUR NEW PROFILE IS: (NASDAQ: NLSP) NLSP HAS OVER 100 PATENTS IN 140 DIFFERENT COUNTRIES JASON MCCARTHY FROM MAXIM GROUP INITIATED A “BUY RATING” ON NLSP WITH A $4.00 PRICE TARGET BACK IN JAN NLSP HAS A LOW FLOAT WITH 14.8 MILLION SHARES COUPLED WITH A WELL FUNDED CASH POSITION OF $8.9MILLION (AS OF DEC. […]